These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35666014)

  • 1. The alprazolam analogue 4'-chloro deschloroalprazolam identified in seized capsules.
    Trigg S; Wells JM; McGann J; Bock S; Holman A; Harrison SM; Goh CY; Moggach SA; Brown DH
    Drug Test Anal; 2022 Sep; 14(9):1672-1680. PubMed ID: 35666014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of the novel designer benzodiazepine 4'-chloro deschloroalprazolam with alprazolam analysis in toxicology and seized drug DUID casework.
    Reber JD; Rodgers C; Ayala JL; Miller J; Stout P; Lee D
    J Anal Toxicol; 2023 Nov; 47(8):680-684. PubMed ID: 37530763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
    Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
    Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
    Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
    Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics.
    Moosmann B; Bisel P; Auwärter V
    Drug Test Anal; 2014; 6(7-8):757-63. PubMed ID: 24604775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics.
    Moosmann B; Huppertz LM; Hutter M; Buchwald A; Ferlaino S; Auwärter V
    J Mass Spectrom; 2013 Nov; 48(11):1150-9. PubMed ID: 24259203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of New Designer Benzodiazepine Diclazepam in Drug Facilitated Sexual Assault].
    Xiang P; Shen BH; Yan H; Liu W; Shen M; Wu HJ; Zhuo XY
    Fa Yi Xue Za Zhi; 2018 Jun; 34(3):248-252. PubMed ID: 30051661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
    Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
    Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry.
    Gwak S; Arroyo-Mora LE; Almirall JR
    Drug Test Anal; 2015 Feb; 7(2):121-30. PubMed ID: 24827678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.
    Cawley AT; Blakey K; Waller CC; McLeod MD; Boyd S; Heather A; McGrath KC; Handelsman DJ; Willis AC
    Drug Test Anal; 2016 Jul; 8(7):621-32. PubMed ID: 27443417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
    Meyer MR; Vollmar C; Schwaninger AE; Wolf E; Maurer HH
    J Mass Spectrom; 2012 Feb; 47(2):253-62. PubMed ID: 22359337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
    Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
    J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
    Zuba D; Sekuła K
    Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl).
    Breindahl T; Kimergård A; Andreasen MF; Pedersen DS
    Drug Test Anal; 2017 Mar; 9(3):415-422. PubMed ID: 27476446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry.
    Takahashi M; Nagashima M; Suzuki J; Seto T; Yasuda I; Yoshida T
    Talanta; 2009 Feb; 77(4):1245-72. PubMed ID: 19084633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018.
    Gundersen POM; Broecker S; Slørdal L; Spigset O; Josefsson M
    Forensic Sci Int; 2020 Jun; 311():110274. PubMed ID: 32302877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
    Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
    Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk.
    Furugen A; Nishimura A; Kobayashi M; Umazume T; Narumi K; Iseki K
    J Pharm Biomed Anal; 2019 May; 168():83-93. PubMed ID: 30798209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.